Capital Research Global Investors
Source: SEC Form 13F · as of Mar 2026Capital Research Global Investors holds 26 biotech & pharma companies tracked by BioSniper, totaling $8.41B in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$8.41B
BioSniper AIPage evidence connected
Prepared research question
What matters most for AMGEN INC (AMGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 6,955,345 | $2.45B |
| JNJJOHNSON & JOHNSON | 8,739,988 | $2.14B |
| AZNASTRAZENECA PLC | 4,611,176 | $901.8M |
| CORCencora Inc. | 1,959,650 | $615.6M |
| IDXXIDEXX LABORATORIES INC /DE | 781,345 | $439.0M |
| MRKMerck & Co., Inc. | 2,061,571 | $248.0M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 3,491,386 | $197.2M |
| TECHBIO-TECHNE Corp | 3,188,210 | $166.6M |
| ZTSZoetis Inc. | 1,408,597 | $166.5M |
| WSTWest Pharmaceutical Services Inc. | 604,011 | $151.4M |
| MOHMolina Healthcare Inc | 1,087,805 | $145.0M |
| KYMRKymera Therapeutics, Inc. | 1,673,275 | $139.4M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 1,115,460 | $97.0M |
| SNYSanofi | 1,661,837 | $80.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 101,891 | $78.7M |
| ALHCAlignment Healthcare Inc. | 3,593,576 | $63.3M |
| BBIOBridgeBio Pharma, Inc. | 763,702 | $56.7M |
| PCVXVaxcyte, Inc. | 912,688 | $53.0M |
| PBHPrestige Consumer Healthcare Inc. | 894,679 | $53.0M |
| CYTKCYTOKINETICS INC | 770,999 | $50.8M |
| DNLIDenali Therapeutics Inc. | 2,514,588 | $48.3M |
| ELVElevance Health Inc. | 119,078 | $34.9M |
| IONSIONIS PHARMACEUTICALS INC | 323,015 | $24.3M |
| BHVNBiohaven Ltd. | 1,332,792 | $11.3M |
| QGENQIAGEN N.V. | 119,998 | $4.7M |
| NVONovo Nordisk A/S | 98,913 | $3.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.